• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2013 Fiscal Year Final Research Report

Analysis of the abnormalities of microRNA and epigenome and the clinical application in gastroenterological cancers

Research Project

  • PDF
Project/Area Number 23390200
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionSapporo Medical University

Principal Investigator

SHINOMURA Yasuhisa  札幌医科大学, 医学部, 教授 (90162619)

Co-Investigator(Kenkyū-buntansha) NOSHO Katsuhiko  札幌医科大学, 医学部, 講師 (10597339)
YAMAMOTO Hiroyuki  聖マリアンナ医科大学, 医学部, 准教授 (40332910)
SUZUKI Hiromu  札幌医科大学, 医学部, 教授 (20381254)
Project Period (FY) 2011 – 2013
Keywords上部消化管学
Research Abstract

MicroRNAs (miRNA) constitute a class of small non-coding RNA molecules that function as post-transcriptional gene regulators. miRNAs can function as oncogenes or tumour suppressors. Therefore, they have been increasingly recognized as useful biomarkers for various human cancers. Metachronous gastric cancer (GC) can develop after endoscopic resection of GC and cannot be predicted based on clinical signature. We identified that DNA methylation of microRNA-34b/c (miR-34b/c) in the mucosa of the noncancerous gastric body may be a useful biomarker for predicting the risk of metachronous GC. With regard to colorectal cancers (CRCs), using miRNA array analysis, we recently discovered that microRNA-31 (miR-31) expression is significantly up-regulated in BRAF-mutated colorectal cancers (CRCs) compared with that in wild-type CRCs. Moreover, associations were identified between miR-31 expression, proximal tumor location and poor prognosis for CRCs. Moreover, the results of functional analysis showed that miR-31 may regulate BRAF activation and that the oncogenic role of miR-31 and its possibility of therapeutic target in CRCs. Thus, our current data suggest that miR-31 may be a diagnostic biomarker and therapeutic target in CRC. These novel data may lead to the establishment of a new therapeutic target or a theranostic procedure in gastroenterological cancers.

  • Research Products

    (24 results)

All 2014 2013 2012 2011 Other

All Journal Article (11 results) (of which Peer Reviewed: 10 results) Presentation (11 results) Remarks (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway2014

    • Author(s)
      Nosho K, Igarashi H, Nojima M, Ito M, Maruyama R, Yoshii S, Naito T, Sukawa Y, Mikami M, Sumioka W, Yamamoto E, Kurokawa S, Adachi Y, Takahashi H, Okuda H, Kusumi T, Hosokawa M, Fujita M, Hasegawa T, Okita K, Hirata K, Suzuki H, Yamamoto H, Shinomura Y.
    • Journal Title

      Carcinogenesis

      Volume: 35 Pages: 776-783

    • Peer Reviewed
  • [Journal Article] The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma2014

    • Author(s)
      Adachi Y, Ohashi H, Imsumran A, Yamamoto H, Matsunaga Y, Taniguchi H, Nosho K, Suzuki H, Sasaki Y, Arimura Y, Carbone DP, Imai K, Shinomura Y.
    • Journal Title

      Tumour Biol.

      Volume: 35 Pages: 973-985

    • Peer Reviewed
  • [Journal Article] HER2 Expression and PI3K-Akt Pathway Alterations in Gastric Cancer2014

    • Author(s)
      Sukawa Y, Yamamoto H, Nosho K, Ito M, Igarashi H, Naito T, Mitsuhashi K, Matsunaga Y, Takahashi T, Mikami M, Adachi Y, Suzuki H, Shinomura Y.
    • Journal Title

      Digestion

      Volume: 89 Pages: 12-17

    • Peer Reviewed
  • [Journal Article] Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk2013

    • Author(s)
      Suzuki R, Yamamoto E, Nojima M, Maruyama R, Yamano HO, Yoshikawa K, Kimura T, Harada T, Ashida M, Niinuma T, Sato A, Nosho K, Yamamoto H, Kai M, Sugai T, Imai K, Suzuki H, Shinomura Y.
    • Journal Title

      J Gastroenterol

      Volume: (in press)

    • Peer Reviewed
  • [Journal Article] Alterations in the HER2-PI3K-Akt pathway in gastric cancer2012

    • Author(s)
      Sukawa Y, Yamamoto H, Nosho K, Kunimoto H, Suzuki H, Adachi Y, Nakazawa M, Nobuoka T, Kawayama M, Mikami M, Matuno T, Hasegawa T, Hirata K, Imai K, Shinomura Y.
    • Journal Title

      World J Gastroenterol

      Volume: 18 Pages: 6577-6586

    • Peer Reviewed
  • [Journal Article] IGF-I receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers2012

    • Author(s)
      Ohashi H, Adachi Y, Yamamoto H, Taniguchi H, Nosho K, Suzuki H, Arimura Y, Imai K, Carbone DP, Shinomura Y.
    • Journal Title

      Cancer Sci.

      Volume: 103 Pages: 252-261

    • Peer Reviewed
  • [Journal Article] Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors2012

    • Author(s)
      Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki Y, Nishida T, Bamba T, Kanda T, Ajioka Y, Taguchi T, Okahara S, Takahashi H, Nishida Y, Hosokawa M, Hasegawa T, Tokino T, Hirata K, Imai K, Toyota M, Shinomura Y.
    • Journal Title

      Cancer Res.

      Volume: 72 Pages: 1126-1136

    • Peer Reviewed
  • [Journal Article] The effective molecular targeted therapies for gastroenterological tumors2012

    • Author(s)
      Nosho K, Shinomura Y.
    • Journal Title

      Medical Science Digest., Japan

      Volume: 38 Pages: 154-157

  • [Journal Article] Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer.2012

    • Author(s)
      Yamamoto H, Adachi Y, Taniguchi H, Kunimoto H, Nosho K, Suzuki H, Shinomura Y.
    • Journal Title

      World J Gastroenterol.

      Volume: 18 Pages: 2745-2755

    • Peer Reviewed
  • [Journal Article] Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer.2012

    • Author(s)
      Maruyama R, Suzuki H, Yamamoto E, Imai K, Shinomura Y.
    • Journal Title

      Tumour Biol.

      Volume: 33 Pages: 275-285

    • Peer Reviewed
  • [Journal Article] Profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer2011

    • Author(s)
      Suzuki H, Takatsuka S, Akashi H, Yamamoto E, Nojima M, Maruyama R, Kai M, Yamano H, Sasaki Y, Tokino T, Shinomura Y, Imai K, Toyota M.
    • Journal Title

      Cancer Res.

      Volume: 71 Pages: 5646-58

    • Peer Reviewed
  • [Presentation] microRNA-34b/c異常メチル化率測定による胃癌の異時性多発リスク予測2013

    • Author(s)
      鈴木 亮,山本英一郎,鈴木 拓,野島正寛,丸山玲緒,能正勝彦,山本博幸,山野泰穂,菅井 有,篠村恭久
    • Organizer
      第110回日本内科学会総会講演会
    • Place of Presentation
      東京
    • Year and Date
      20130400
  • [Presentation] 大腸腫瘍におけるKRAS、BRAF、PIK3CA 変異と相関を示すmicroRNA の同定を目指したアレイシステムによる網羅的2013

    • Author(s)
      能正勝彦, 篠村恭久
    • Organizer
      第99回日本消化器病学会総会
    • Place of Presentation
      鹿児島
    • Year and Date
      20130300
  • [Presentation] microRNA-34b/cの異常メチル化は胃癌の異時性多発リスクに関与する2013

    • Author(s)
      鈴木 亮,篠村恭久
    • Organizer
      シンポジウム6HP除菌後の病態と対応 : 第99回日本消化器病学会総会
    • Place of Presentation
      鹿児島
    • Year and Date
      20130300
  • [Presentation] The relation of LINE methylation level and macroscopic type in colorectal adenoma and pT1 colorectal cancer2013

    • Author(s)
      Katsuhiko Nosho, Yasuhisa Shinomura
    • Organizer
      Ninth AACR-Japanese Cancer Association Joint Conference
    • Place of Presentation
      Hawaii, USA
    • Year and Date
      20130200
  • [Presentation] 腸癌におけるLINE-1メチル化レベルとmicroRNA発現を標的とした診断・個別化治療への応用2013

    • Author(s)
      能正勝彦, 篠村恭久
    • Organizer
      第9回日本消化管学会総会学術集会
    • Place of Presentation
      東京都
    • Year and Date
      20130100
  • [Presentation] 腸癌のグローバル DNA メチル化、microRNA 異常発現の解析とそれらを標的とした新規バイオマーカーの探索と大腸発癌の検討2012

    • Author(s)
      能正勝彦, 篠村恭久
    • Organizer
      第 23 回日本消化器癌発生学会
    • Place of Presentation
      鳴門
    • Year and Date
      20121100
  • [Presentation] 大腸癌の分子診断学における LINE-1 メチル化レベルの重要性と microRNA 発現の網羅的解析2012

    • Author(s)
      能正勝彦, 篠村恭久
    • Organizer
      JDDW2012
    • Place of Presentation
      神戸
    • Year and Date
      20121000
  • [Presentation] Comprehensive analysis of the genome-wide DNA methylation and microRNA expression in gastrointestinal cancers and the identification of new biomarkers targeting those alterations2012

    • Author(s)
      能正勝彦, 篠村恭久
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌
    • Year and Date
      20120900
  • [Presentation] Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors.2012

    • Author(s)
      鈴木 拓,新沼 猛,野島正寛,丸山玲緒,山本英一郎,甲斐正広,能正勝彦,山本博幸,時野隆至,今井浩三,篠村恭久
    • Organizer
      第71回日本癌学会学術集会
    • Place of Presentation
      札幌
    • Year and Date
      20120900
  • [Presentation] 消化管間質腫瘍におけるmicroRNA発現プロファイル解析2012

    • Author(s)
      鈴木 拓,新沼 猛,野島正寛,山本英一郎,丸山玲緒,山本博幸,篠村恭久
    • Organizer
      第49回日本臨床分子医学会学術集会
    • Place of Presentation
      京都
    • Year and Date
      20120400
  • [Presentation] GISTの悪性度マーカーおよび治療標的としての non-coding RNA2012

    • Author(s)
      新沼 猛,鈴木 拓,野島正寛,高丸博之,山本英一郎,能正勝彦,山本博幸,篠村恭久
    • Organizer
      第8回日本消化管学会総会学術集会
    • Place of Presentation
      仙台
    • Year and Date
      20120200
  • [Remarks]

    • URL

      http://web.sapmed.ac.jp/im1/

  • [Patent(Industrial Property Rights)] 腸癌を治療および/または診断するための組成物ならびにその利用2013

    • Inventor(s)
      篠村 恭久, 能正勝彦, 山本博幸, 鈴木拓
    • Industrial Property Rights Holder
      北海道公立大学法人 札幌医科大学
    • Industrial Property Number
      特願 2013-126021
    • Filing Date
      2013-06-14

URL: 

Published: 2015-03-12  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi